GETZLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug GETZLOX contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9537	Tablet	GETZLOX TABLET TAB 500 mg 1 X 10	GETZLOX TABLET GETZLOX LEVOFLOXACIN 750MG POM TABLET 1 X 10 ANTIBIOTIC GETZ PHARMA LIMITED. 13B CAPPA AVENUE, PALMGROVE STREET, ILUPEJU, LAGOS STATE. GETZ PHARMA PVT. LIMITED. 29-30/27 KORANGI INDUSTRIAL AREA, KARACHI-74900, PAKISTAN. GMP- SATIS; LR- SATIS/FLAF; FEES- PAID; NP:NA 28/11/2017 A4-9537	30/01/2020
A4-9539	Solution for infusion	GETZLOX INFUSION INJ_SOL 500 mg/100 mL 1 X 100ML	GETZLOX INFUSION GETZLOX LEVOFLOXACIN 500MG/100ML POM INFUSION 1 X 100ML ANTIBIOTIC GETZ PHARMA LIMITED. 13B CAPPA AVENUE, PALMGROVE STREET, ILUPEJU, LAGOS STATE. GETZ PHARMA PVT. LIMITED. 29-30/27 KORANGI INDUSTRIAL AREA, KARACHI-74900, PAKISTAN. GMP- SATIS; LR- SATIS/FLAF; FEES- PAID; NP:NA 28/11/2017 A4-9539	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-9537, A4-9539